Nanoform Finland Oyj
OMXH:NANOFH
Nanoform Finland Oyj
Nanoform Finland Oyj engages in providing expert services in nanotechnology and drug particle engineering for the international pharma industry. The company is headquartered in Helsinki, Etela-Suomen and currently employs 158 full-time employees. The company went IPO on 2020-06-04. The firm is an early-stage growth Company that develops various nanoforming technologies for application in the field of nanomedicine. Nanoform Finland Oyj’s business is to offer expert services in nanotechnology as well as drug particle engineering for global pharma and biotech industry. Nanoform Finland Oyj is the Parent Company of the Nanoform Group, and it has one subsidiary - Nanoform USA Inc. The Group production, research and development functions operate in Finland. The Group’s strategy is to sell nanotechnological services widely to minimize the dependence from single customers or projects.
Nanoform Finland Oyj engages in providing expert services in nanotechnology and drug particle engineering for the international pharma industry. The company is headquartered in Helsinki, Etela-Suomen and currently employs 158 full-time employees. The company went IPO on 2020-06-04. The firm is an early-stage growth Company that develops various nanoforming technologies for application in the field of nanomedicine. Nanoform Finland Oyj’s business is to offer expert services in nanotechnology as well as drug particle engineering for global pharma and biotech industry. Nanoform Finland Oyj is the Parent Company of the Nanoform Group, and it has one subsidiary - Nanoform USA Inc. The Group production, research and development functions operate in Finland. The Group’s strategy is to sell nanotechnological services widely to minimize the dependence from single customers or projects.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
